Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Date
2022-12-01
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Burkill, S, Porsbjerg, C M, Bourdin, A, Tran, T N, Martin, N, Katial, R, Barker, P, Wechsler, M E, Maspero, J F, Bosnic-Anticevich, S, Chung, L P, Katsoulotos, G, Christoff, G, Popov, T A, Sadatsafavi, M, Torres-Duque, C A, Ulrik, C, Assing, K D, Hansen, S, Altraja, A, Lehtimäki, L A, Papadopoulos, N G, Kostikas, K, Salvi, S, Costello, R W, Puggioni, F, Iwanaga, T, Rhee, C K, Al-Ahmad, M, Larenas-Linnemann, D, Fonseca, J A, Amaral, R, Al-Lehebi, R, Perez de Llano, L, Kirenga, B, Tsai, M-J, Mahboub, B, Pfeffer, P E, Henley, W, Liu, Y, Lyu, J, Goh, C, Uthaman, T, Price, D & ISAR IGNITE 2022, 'Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients', European Respiratory Journal, vol. 60, no. 66, 3305. https://doi.org/10.1183/13993003.congress-2022.3305